Cyhoeddiad
2026
- Lucas-Clarke, H. J. et al., 2026. Alzheimer’s disease risk gene Wwox controls amyloid pathology through metabolic reprogramming. Brain Communications fcag385. (10.1093/braincomms/fcag385)
- Storer, F. et al. 2026. Phosphoinositide turnover through PLCγ regulates Draper-dependent engulfment in glia [Pre-print]. bioRxiv (10.64898/2026.06.04.729572)
2025
- Lucas-Clarke, H. J. et al. 2025. Alzheimer’s disease risk gene Wwox protects against amyloid pathology through metabolic reprogramming [Pre-print]. bioRxiv (10.1101/2025.05.01.651195)
2023
- Maddison, D. C. et al. 2023. COPI-regulated mitochondria-ER contact site formation maintains axonal integrity. Cell Reports 42 (8) 112883. (10.1016/j.celrep.2023.112883)
Erthyglau
- Lucas-Clarke, H. J. et al., 2026. Alzheimer’s disease risk gene Wwox controls amyloid pathology through metabolic reprogramming. Brain Communications fcag385. (10.1093/braincomms/fcag385)
- Storer, F. et al. 2026. Phosphoinositide turnover through PLCγ regulates Draper-dependent engulfment in glia [Pre-print]. bioRxiv (10.64898/2026.06.04.729572)
- Lucas-Clarke, H. J. et al. 2025. Alzheimer’s disease risk gene Wwox protects against amyloid pathology through metabolic reprogramming [Pre-print]. bioRxiv (10.1101/2025.05.01.651195)
- Maddison, D. C. et al. 2023. COPI-regulated mitochondria-ER contact site formation maintains axonal integrity. Cell Reports 42 (8) 112883. (10.1016/j.celrep.2023.112883)